Get Cash Back and $0 Commissions
+ The Power of TradeStation
PRNewswire 13-Feb-2024 11:45 AM
NEW YORK, Feb. 13, 2024 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ:HOTH), a biopharmaceutical company, today announced that Robb Knie, Chief Executive Officer, is scheduled to attend the BIO CEO and Investor Conference in New York, NY.
To learn more about BIO CEO and Investor Conference please visit https://bcic.bio.org/.
About Hoth Therapeutics, Inc.
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for dermatological disorders. Hoth's pipeline has the potential to improve the quality of life for patients suffering from indications including atopic dermatitis, chronic wounds, psoriasis, asthma, and acne. Hoth has also recently entered into two different agreements to further the development of two different vaccine prospects to prevent or treat COVID-19. To learn more, please visit https://ir.hoththerapeutics.com/.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hoth-therapeutics-to-attend-bio-ceo-and-investor-conference-february-26-27-2024-302060867.html
SOURCE Hoth Therapeutics, Inc.